top of page
HOME
ABOUT
Management
Board of Directors
Advisors
Values
PIPELINE
iQ-007
iQ-008
NEWS
CONTACT US
More
Use tab to navigate through the menu items.
News
All Posts
People
Business
Science
Search
iQ-007: Confirmation of Safety Profile and Second Indication by NINDS (US)
Delaware – January 2020, iQure Pharma Inc., a company dedicated to preclinical and early development of Oncology and Central Nervous...
Jan 23, 2020
JPM Week
No Abuse
bottom of page
